Pharma Reports

Market Scope surveys physicians regarding procedure volumes, surgical techniques, and product use. We use this data, along with our extensive database of physicians and surgery centers, our wide-ranging knowledge of products and technology, and our comprehensive network of industry contacts, to regularly report on the ophthalmic and orthopedic industries.

Newest First

2019 Glaucoma Pharmaceuticals Market Report: A Global Analysis for 2018 to 2024, June, 2019

The 2019 Glaucoma Pharmaceuticals Report is Market Scope’s comprehensive analysis of the glaucoma pharmaceutical segment of ophthalmology. Our report is designed for members of the ophthalmic industry who participate in this market or are weighing doing so, market analysts, ophthalmologists who treat glaucoma patients, investors, and any other parties who may be interested in the global marketplace of glaucoma pharmaceuticals.

2018 Retinal Pharmaceuticals Report: A Global Market Analysis for 2017-2023, October, 2018

Our report on the retinal pharmaceuticals and biologics market is in its ninth edition. It is a leading industry source for accurate and relevant information on all aspects of the market. We cover prevalence and forecasts for retinal diseases and conditions. We discuss therapeutic approaches and mechanisms of action under investigation. We discuss the market dynamics for currently commercialized products and the rich and crowded pipeline of investigational therapies. We review patient-based economic issues and reimbursement and analyze treatment patterns and trends. We also forecast product demand in units and dollars, and we analyze market shares by product category. 

Want to Purchase the Full Report?

Register A Corporate Account

A corporate accounts gives you access to licensed reports and subscriptions, the latest news, and a personalized dashboard.

Select one or more
Select one or more

Market Scope

13421 Manchester Road, Suite 201 | St. Louis, MO 63131 | Phone: 314-835-0600 | Email:

©2019 Market Scope, LLC. All Rights reserved.